Omalizumab
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4592 publications
A Systematic Review of the Specific Role of Biological Therapies in Aspirin-Exacerbated Respiratory Disease.
Journal: Journal of investigational allergology & clinical immunology
Published: January 20, 2026
How do I treat : allergic bronchopulmonary aspergillosis in patients with cystic fibrosis
Journal: Revue medicale de Liege
Published: January 15, 2026
Predictors of relapse after omalizumab withdrawal in chronic spontaneous urticaria: Role of baseline autoimmunity and hematologic indices: CSU Relapse After Omalizumab Withdrawal.
Journal: Allergy and asthma proceedings
Published: January 09, 2026
Omalizumab: First Approved Anti-IgE Therapy for Multiple Food Allergies.
Journal: American journal of therapeutics
Published: January 08, 2026
Omalizumab Treatment for Pregnancy With Refractory Acute Urticaria.
Journal: American journal of therapeutics
Published: January 08, 2026
Remibrutinib (Rhapsido) for chronic spontaneous urticaria.
Journal: The Medical letter on drugs and therapeutics
Published: January 08, 2026
Comparative analysis of the manufacturing carbon footprint of biologics for severe asthma.
Journal: BMJ open
Published: January 07, 2026
Endoscopic sinus surgery versus biologic therapy for chronic rhinosinusitis with nasal polyposis: a systematic review with meta-analysis.
Journal: Rhinology
Published: January 05, 2026
Appropriate use of biologics in management of chronic rhinosinusitis with nasal polyposis.
Journal: Current opinion in otolaryngology & head and neck surgery
Published: December 24, 2025
Cold Urticaria Preventing Clearance For Scientific Diving.
Journal: Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc
Published: December 22, 2025
The biologic paradox solved? The imminent arrival of omalizumab biosimilars in Europe.
Journal: Journal of medical economics
Published: December 19, 2025
Late-onset inflammatory reaction with panniculitis and persistent edema following dermal fillers, successfully treated with omalizumab.
Journal: Italian journal of dermatology and venereology
Published: December 11, 2025
Last Updated: 02/24/2026